Companies: 49,246 Total Market Cap: 132386205533959.40

PT Kalbe Farma Tbk.

OTC-PTKFF
Healthcare Drug Manufacturers - General
Rank #3742
Market Cap 4.04 B
Volume 3,500
Price 0.08
Change (%) 15.54%
Country or region Indonesia Indonesia

PT Kalbe Farma Tbk.'s latest marketcap:

4.04 B

As of 05/20/2025, PT Kalbe Farma Tbk.'s market capitalization has reached $4.04 B. According to our data, PT Kalbe Farma Tbk. is the 3742th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.

Market Cap 4.04 B
Revenue (ttm) 2.00 B
Net Income (ttm) 202.90 M
Shares Out 0
EPS (ttm) 0
Forward PE 18.31
Ex-Dividend Date n/a
Earnings Date 04/27/2025
Market Cap Chart
Data Updated: 05/20/2025

PT Kalbe Farma Tbk.'s yearly market capitalization.

PT Kalbe Farma Tbk. has seen its market value drop from $4.95 B to $4.04 B since 2020, representing a total decrease of 18.39% and an annual compound decline rate (CAGR) of 4.53%.
Date Market Cap Change (%)
05/20/2025 $4.04 B 3.78%
12/30/2024 $3.89 B -19.49%
12/29/2023 $4.83 B -22.39%
12/30/2022 $6.23 B 17.3%
12/30/2021 $5.31 B 7.29%
12/30/2020 $4.95 B

Company Profile

About PT Kalbe Farma Tbk.

PT Kalbe Farma Tbk., along with its subsidiaries, is a leading pharmaceutical company in Indonesia. Established in 1966 and headquartered in Jakarta, the company specializes in developing, manufacturing, and trading a wide range of healthcare products.

Business Divisions

The company operates through four key divisions:

  • Prescription Pharmaceuticals – Focused on ethical and prescription medicines.
  • Consumer Health – Offers over-the-counter healthcare products.
  • Nutritionals – Provides nutritional supplements and health foods.
  • Distribution and Logistics – Manages supply chain and distribution services.

Product & Service Offerings

Kalbe Farma delivers a diverse portfolio, including:

  • Prescription and consumer health products.
  • Nutritional supplements and biopharmaceuticals.
  • Medical devices and animal health products.
  • Health services through Mitrasana Clinics.
  • Distribution of medical equipment, cosmetics, and raw materials.
  • Advertising and health screening services.

With a strong presence in Indonesia, Kalbe Farma continues to expand its international business and e-health initiatives, reinforcing its commitment to improving healthcare accessibility.

Frequently Asked Questions

As of 05/20/2025, PT Kalbe Farma Tbk. (including the parent company, if applicable) has an estimated market capitalization of $4.04 B USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.

PT Kalbe Farma Tbk. global market capitalization ranking is approximately 3742 as of 05/20/2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.

Stock Detail

Country or region Indonesia
Founded 1966
IPO Date n/a
Employees 12,903
CEO Bernadette Ruth Setiady
Sector Healthcare
Industry Drug Manufacturers - General
Address Gedung KALBE
Jakarta, 10510
Indonesia
Website https://www.kalbe.co.id
People Also Watch
Eli Lilly
744.70 15.54%
JNJ
153.40 15.54%
AbbVie
184.20 15.54%
Novo Nordisk
67.76 15.54%